Acne Treatment Products Recalled for Improper Storage Conditions
Family Dollar Stores is recalling two acne treatment products due to storage condition deviations. The products were held outside appropriate temperature ranges.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall based on Current Good Manufacturing Practice (CGMP) deviations related to improper storage conditions. The recall is precautionary in nature, addressing manufacturing process deviations rather than confirmed product harm or adverse events.
Plain-English summary
Family Dollar Stores, LLC is recalling two ACNE FREE acne treatment products: ACNE FREE ADAPALENE GL ACN TRTMT (0.5 oz, SKU 2096518) and ACNE FREE TRMINTR 10 SPOT TRTMT (1 oz, SKU 2096507).
These products are being recalled due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the products were held outside of appropriate storage temperature conditions during distribution.
The affected products were distributed nationwide to specific Family Dollar Stores locations between April 30, 2022 and June 10, 2022.
Consumers who have purchased these products should stop using them and contact Family Dollar Stores for instructions on product return or disposal.
The recalled product
- Product
- ACNE FREE ADAPALENE GL ACN TRTMT 0.5 OZ SKU 2096518 ACNE FREE TRMINTR 10 SPOT TRTMT 1 OZ SKU 2096507 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Acne Treatment
- Hazard
- temperature-deviation
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 2096518
- 2096507
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27